Facts & Figures

Merz Pharma Group

Merz is a privately held pharmaceutical company based in Frankfurt, Germany with affiliates across Europe, as well as the US, Canada, Mexico, Brazil and Asia Pacific. The company is active in research, development and distribution of innovative products in the areas of aesthetic medicine and neurologically induced movement disorders.

In German-speaking countries, our consumer products segment, Merz Consumer Care, is a leading provider of innovative health, wellness and beauty products with its well-known tetesept® and Merz Spezial® brands.

Facts & Figures

Global Headquarters:Frankfurt am Main, Germany
Affiliates: Argentina, Australia, Austria, Brazil, Canada, China, Colombia, France, Germany, Great Britain, India, Indonesia, Italy, Malaysia, Mexico, Philippines, Russia, Singapore, Spain, South Korea, Switzerland, Taiwan, Thailand, The Netherlands, United Arab Emirates, USA, Vietnam
Status: Privately held
Fiscal Year: July 1 – June 30


2015/ 20162014/ 2015Change %
RevenueEUR1.092,9 1.157,0 -5,5%
EMEAEUR 352,4345,22,1%
North AmericaEUR377,0325,315,9%
Latin AmericaEUR55,148,413,8%
Licenses / CorporateEUR227,4376,2-39,6%
Results of operations
EBITEUR131,8255,6 -48,4%
EBIT margin%12,0 22,0
EBT EUR 111,6235,4 -52,6%
Net income EUR 70,6156,5 -54,9%
Cash flow from operating activities EUR 200,3330,6 -39,4%
Research and development
Research and development expenses EUR 160,2148,8 7,7%
As % of revenue % 14,712,9
Financial position & net assets
Total assets EUR 1.510,2 1.549,0 -2,5%
Headcount as of the end of the reporting period 3.005 2.754 9,1%

Key Products:

  • Belotero®
  • Xeomin® / Bocouture®
  • Radiesse®
  • Ultherapy®
  • Cellfina®
  • Axura®/ Namenda®
  • PK-Merz®
  • Contractubex® / Mederma®
  • Pantogar® / Pantovigar®
  • Hepa-Merz®
  • Tetesept – products
  • Merz Spezial – products